Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

Lihan Zhou, CEO and Co-Founder of Mirxes, a Singapore-based bio-test company, discusses the company's Hong Kong IPO and ...

In related news, Singapore-based pharmaceutical company Mirxes, which specializes in cancer treatment, also had a strong debut in Hong Kong on the same day. The company’s shares rose by 28% in morning ...

In response to Fitch maintaining Hong Kong's AA- credit rating and stable outlook, the Hong Kong Special Administrative ...

Top-ranked Hong Kong university welcomes international Harvard students to transfer or enroll in degree programs ...

Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 ...

Dow Jones Top Company Headlines at 11 AM ET: Booz Allen to Cut 2,500 Jobs as Business Grapples With Trump Spending Crackdown | Trump ... Booz Allen to Cut 2,500 Jobs as Business Grapples With Trump ...

Hong Kong stocks generally maintained their strong momentum, with the weekly performances of the three major indices varying. By the close of trading, the Hang Seng Index (HSI) had risen by 1.10% week ...

Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 ...

Dow Jones Top Company Headlines at 5 AM ET: Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them. | America’s ... Strokes and Heart Attacks Kill. New Drugs Are Coming to Prevent Them ...

Two VC-backed companies debuted on US exchanges this week, both of which priced at the top of the range and traded up.